1. Home
  2. SLNO vs AKR Comparison

SLNO vs AKR Comparison

Compare SLNO & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • AKR
  • Stock Information
  • Founded
  • SLNO 1999
  • AKR 1993
  • Country
  • SLNO United States
  • AKR United States
  • Employees
  • SLNO N/A
  • AKR N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AKR Real Estate Investment Trusts
  • Sector
  • SLNO Health Care
  • AKR Real Estate
  • Exchange
  • SLNO Nasdaq
  • AKR Nasdaq
  • Market Cap
  • SLNO 2.3B
  • AKR 2.2B
  • IPO Year
  • SLNO 2014
  • AKR 1993
  • Fundamental
  • Price
  • SLNO $71.99
  • AKR $21.02
  • Analyst Decision
  • SLNO Strong Buy
  • AKR Buy
  • Analyst Count
  • SLNO 8
  • AKR 4
  • Target Price
  • SLNO $92.00
  • AKR $23.00
  • AVG Volume (30 Days)
  • SLNO 1.8M
  • AKR 1.3M
  • Earning Date
  • SLNO 05-08-2025
  • AKR 04-28-2025
  • Dividend Yield
  • SLNO N/A
  • AKR 3.61%
  • EPS Growth
  • SLNO N/A
  • AKR N/A
  • EPS
  • SLNO N/A
  • AKR 0.19
  • Revenue
  • SLNO N/A
  • AKR $375,840,000.00
  • Revenue This Year
  • SLNO N/A
  • AKR N/A
  • Revenue Next Year
  • SLNO N/A
  • AKR $24.22
  • P/E Ratio
  • SLNO N/A
  • AKR $111.24
  • Revenue Growth
  • SLNO N/A
  • AKR 13.20
  • 52 Week Low
  • SLNO $36.61
  • AKR $16.14
  • 52 Week High
  • SLNO $73.97
  • AKR $26.29
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 84.44
  • AKR 36.37
  • Support Level
  • SLNO $48.29
  • AKR $20.81
  • Resistance Level
  • SLNO $51.88
  • AKR $21.50
  • Average True Range (ATR)
  • SLNO 3.03
  • AKR 0.49
  • MACD
  • SLNO 2.32
  • AKR -0.01
  • Stochastic Oscillator
  • SLNO 93.61
  • AKR 12.28

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

Share on Social Networks: